Chenguang Biotech Group Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Chenguang Biotech Group Co.,Ltd.. Fundamentals are ordered by how Chenguang Biotech Group Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash from minority shareholders of subsidiaries5,500,0000.00215662015-06-30historic
Refunds of taxes16,119,9950.006311062015-06-30historic
Capital reserve635,505,3630.24871482015-06-30historic
Non-operating loss1,340,8635.2E-41642015-06-30historic
Inventories479,014,5710.187462112015-06-30historic
Construction materials127,0365.0E-52112015-06-30historic
Diluted eps00.02262015-06-30historic
Revenue677,509,1240.265142712015-06-30historic
Total cost of goods sold643,651,3130.251892782015-06-30historic
Other current assets65,263,2350.025542872015-06-30historic
Cash paid for other investing activities1,000,0003.9E-42872015-06-30historic
Intangible assets95,925,2330.037542972015-06-30historic
Cash inflows from operating activities714,084,8040.279453082015-06-30historic
Cash outflows from operating activities662,191,0650.259143242015-06-30historic
Net income40,538,3860.015863272015-06-30historic
Total profit48,490,6500.018983312015-06-30historic
Prepayment51,604,9270.02023312015-06-30historic
Fixed assets446,705,2490.174823552015-06-30historic
Total comprehensive income39,650,5480.015523592015-06-30historic
Short term borrowings207,620,3200.081254122015-06-30historic
Disposal of fixed assets and others75,4203.0E-54592015-06-30historic
Operating profit33,857,8110.013254602015-06-30historic
Financial expenses6,919,1680.002714862015-06-30historic
Selling expenses18,053,5010.007074982015-06-30historic
Total non-current assets592,027,7520.231695482015-06-30historic
Deferred tax assets6,559,9120.002575712015-06-30historic
Net cash flows from investing activities-16,841,458-0.006595732015-06-30historic
Total liabilities and equity1,399,662,1630.547755822015-06-30historic
Cash paid for other financing activities443,2001.7E-45902015-06-30historic
Interests payable293,1361.1E-45932015-06-30historic
Goodwill593,8592.3E-46122015-06-30historic
Cash paid for taxes20,609,5380.008076292015-06-30historic
Notes receivable7,338,9000.002876762015-06-30historic
Other receivables10,159,1080.003986882015-06-30historic
Purchases of fixed assets and others13,949,5280.005467302015-06-30historic
Payroll payable4,028,4200.001587742015-06-30historic
Total liabilities350,650,5770.137237752015-06-30historic
Comprehensive income attributable to minority shareholders-186,267-7.0E-57842015-06-30historic
Cash paid for dividends, profits or interests10,939,3980.004287932015-06-30historic
Minority interests gain-186,267-7.0E-57972015-06-30historic
Minority interest5,457,0750.002148142015-06-30historic
Cash inflows from financing activities87,525,6800.034258162015-06-30historic
Other payables12,030,6030.004718272015-06-30historic
Accounts payable35,583,7240.013939662015-06-30historic
Net cash and cash equivalents ending balance53,357,2160.0208810892015-06-30historic
Net change in cash-81,140,223-0.0317511732015-06-30historic
Net cashflow from financing activities-116,490,843-0.0455912562015-06-30historic